renal replacement therapy – Page 2 – Communicable Diseases Research

Ability of IMPROVE and IMPROVE-DD scores to predict outcomes in patients with severe COVID-19: a prospective observational study

Observational Study

Published on 2022-08-032022-10-04
Journal: Scientific Reports [Category] 임상, 치료기술, 치료법,

Phenotypic Heterogeneity of Fulminant COVID-19–Related Myocarditis in Adults

전격성 COVID-19의 표현형 이질성-성인의 심근염 관련

Article

Published on 2022-07-262022-09-12
Journal: Journal of the American College of Cardiology [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술,

[키워드] age autoantibody Characteristics characterized circulating Clinical outcome Clinical presentations COVID-19 COVID-19 symptom criteria Cytokines develop Ejection fraction extracorporeal membrane oxygenation fulminant fulminant myocarditis ICU ICU admission IFN-α2 IL-17 IL-8 immunological infected with SARS-CoV-2 Inflammatory intensive care male management mechanical ventilation Mortality Multisystem inflammatory syndrome myocarditis Organ failure pathophysiology Patient patients phenotype profiles Prognosis renal replacement therapy required Retrospective analysis RNA polymerase RNA polymerase III autoantibodies SARS-CoV-2 Support syndrome TNF-α Treatment tumor necrosis factor-α VA-ECMO ventricular
[DOI] 10.1016/j.jacc.2022.04.056 PMC 바로가기 [Article Type] Article

Rhabdomyolysis-Induced AKI (RIAKI) Including the Role of COVID-19

COVID-19의 역할을 포함한 횡문근 융해 유발 AKI(RIAKI)

Review

Published on 2022-07-262022-09-11
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술,

[키워드] acute kidney Acute kidney injury acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration AKI aspartate Aspartate aminotransferase AST bloodstream caused Cell combination therapy Complication contribute coronavirus Course COVID-19 COVID-19 disease creatine creatine kinase damage defined develop Diagnosis disease drugs escape Factors FIVE Fluid resuscitation furosemide high mortality rate in some Including Lactate lactate dehydrogenase LDH life-threatening limit mannitol many cases marker muscle pain Myoglobin occur Pain Patient patients Potassium renal renal replacement therapy replacement therapy required respiratory rhabdomyolysis role RRT SARS-CoV-2 serious complication serum severe acute respiratory syndrome Coronavirus Side effect Side effects sodium sodium bicarbonate statin Striated muscle therapeutic interventions therapy Treatment uridine
[DOI] 10.3390/ijms23158215 PMC 바로가기 [Article Type] Review

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Clinical Trial

Published on 2022-07-082022-10-05
Journal: The Lancet. Respiratory Medicine [Category] 임상, 진단, 치료법,

[키워드] 1:1 addition adverse event Analysis assigned baseline Cohort Complete COVID-19 cumulative defined double-blind Europe extracorporeal membrane oxygenation finding Follow-up funding hazard ratio hospital discharge hospitalised hypothesised IMPROVE incidence infused intravenous Invasive mechanical ventilation investigators modified intention-to-treat monoclonal antibody combination Mortality neutralising NIH occurred operation Organ failure outcome participant Patient Phase 3 phase 3 trial Placebo placebo group placebo-controlled trial Primary outcome randomised Randomly receive receiving Registered Remdesivir renal replacement therapy Result Safe seronegative Singapore speed standard care study drug Study participants Support sustained Symptom the placebo group therapy Treatment Uganda USA were excluded with COVID-19
[DOI] 10.1016/S2213-2600(22)00215-6 [Article Type] Clinical Trial

COVID-19 and Acute Kidney Injury

Review article

Published on 2022-07-012022-10-05
Journal: Critical Care Clinics [Category] COVID19(2023년), SARS, 바이오마커,

[키워드] Acute kidney injury Blood purification techniques COVID-19 Cytokines renal replacement therapy
[DOI] 10.1016/j.ccc.2022.01.002 [Article Type] Review article

Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

Randomized Controlled Trial

Published on 2022-07-012022-10-04
Journal: Intensive care medicine [Category] COVID19(2023년), SARS, 임상,

[키워드] active smoker Acute respiratory failure Administered Adverse affected artificial assessment assigned Care conducted confidence interval coronavirus disease COVID-19 Critically ill patient daily dose days alive dose double-blind Efficacy and safety event France function intensive care unit intensive care units Invasive mechanical ventilation IQR mechanical ventilation median men Mortality multicentre Nicotine Nicotinic receptor not differ Odds ratio on mechanical ventilation Organ failure Patient Placebo placebo-controlled placebo-controlled trial Pneumonia Primary outcome Randomized randomized trial Randomly receive receiving reduce renal replacement therapy secondary outcome Severe COVID-19 pneumonia significantly smoker stratified symptomatic patient the median the placebo group Trial two group two groups vasopressor support Ventilation ventilator-free day with COVID-19
[DOI] 10.1007/s00134-022-06721-1 PMC 바로가기 [Article Type] Randomized Controlled Trial

COVID-19 and acute kidney injury in German hospitals 2020

독일 병원의 COVID-19 및 급성 신장 손상 2020

Article

Published on 2022-06-092022-09-11
Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% CI 95%CI Acute kidney injury age AKI bimodal calculated Course COVID-19 COVID-19 diagnosis COVID-19 hospitalization COVID-19 infection denominator diagnosed Diagnosis females Germany healthcare professionals high mortality highest hospital Hospitalization hospitalizations hospitals in-hospital mortality in-hospital mortality rate increase in initial involved less lung involvement male material Mortality multiple organ multiple organs observation period occurred overall mortality pandemic patients peaked performed person year person years Population portal Prognosis proportion provide rate ratio Relative risk remained remuneration renal replacement therapy replacement therapy retrospective risk RRT RT-PCR SARS-CoV-2 pandemic Secondary diagnosis spring SRR Stage therapy was performed while with COVID-19
[DOI] 10.1371/journal.pone.0264510 PMC 바로가기 [Article Type] Article

Characteristics and outcomes of sepsis patients with and without COVID-19

Research article

Published on 2022-06-012022-10-05
Journal: Journal of infection and public health [Category] 바이오마커,

[키워드] Acute kidney injury acute respiratory distress syndrome adjusted adjusted relative risk AKIAcute Kidney Injury Analysis analyzed ARDSacute respiratory distress syndrome BMIbody mass index body mass index C-reactive protein Characteristics CIconfidence interval Clinical characteristics confidence interval Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients COVID-19coronavirus disease 2019 Critically ill CRPC-reactive protein CRScytokine release syndrome Cytokine release syndrome diagnosed ECMOextracorporeal membrane oxygenation extracorporeal membrane oxygenation facilitate HAIHospital acquired infection High-risk patients Hospital acquired infection ICU admission ICU patient ICUIntensive Care Unit identify IL-6interleukin 6 in-hospital mortality independent risk factor Inhaled nitric oxide iNOInhaled nitric oxide intensive care unit interleukin 6 invasive ventilation Kaplan-Meier estimator lactate dehydrogenase LDHlactate dehydrogenase medical icu Mortality not differ outcome Patient patients PCT PCTProcalcitonin Poisson regression procalcitonin Relative risk renal replacement therapy Result risk factor robust RRRelative risk RRTRenal replacement therapy screened Sepsis sepsis patient sepsis patients septic patient septic patients Septic shock sequential organ failure assessment score Sex significantly significantly higher SOFA score SOFA scoreSequential organ failure assessment score surgical survival treated university were assessed WHOWorld Health Organization World Health Organization
[DOI] 10.1016/j.jiph.2022.05.008 [Article Type] Research article

Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies

투석 환자에서 BNT162b2에 이어 mRNA-1273으로 이종 면역화: 혈청전환 및 중화항체 존재

Article

Published on 2022-05-252022-09-12
Journal: Nephrology, dialysis, transplantation : official p [Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] acute respiratory syndrome Analysis anti-SARS-CoV-2 antibodies antibody BNT162b2 boost booster Cambridge Characteristics Concentration coronavirus COVID-19 cut-off dialysis disease dose Efficacy Elasomeran Elecsy Genscript Germany heterologous immunization high risk Humoral immunity immunoreactivity Immunosuppression Infection Mainz Moderna Mortality mRNA vaccine mRNA-1273 mRNA-1273 booster neutralization Neutralization assay Neutralizing antibodies neutralizing antibody of BNT162b2 Patient patients performed plaque reduction neutralization PRNT receiver receiving renal replacement therapy ROC Roche Diagnostics SARS-CoV-2 SARS-CoV-2 spike Seroconversion surrogate Test the SARS-CoV-2 titre Tozinameran USA vaccination virus-neutralizing was measured was reduced were measured were used while wild-type SARS-CoV-2 York
[DOI] 10.1093/ndt/gfac018 PMC 바로가기 [Article Type] Article

Comparison of clinical characteristics and outcomes of COVID-19 patients undergoing early versus late intubation from initial hospital admission: A systematic review and meta-analysis

Review article

Published on 2022-05-012022-10-05
Journal: Respiratory investigation [Category] COVID19(2023년), SARS, 바이오마커, 임상,

[키워드] 95% confidence interval age Alter body mass index Clinical characteristics Clinical outcome Cochrane Library cohort study comparable coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient database defined delayed intubation determine diabetes Early intubation early phase explain First wave hospital Hospital admission hospital mortality rate IMV in-hospital mortality initial intubation Invasive mechanical ventilation Late intubation mechanical ventilation Meta-analysis mortality rate no significant difference Odds ratio Organ failure outcome pandemic Patient Primary outcome renal replacement therapy required Research Result RRT SARS-CoV-2 searched Sex significantly SOFA SOFA score systematic review Therapies Web of Science while
[DOI] 10.1016/j.resinv.2022.02.007 [Article Type] Review article